Neoadjuvant Combination of Atezolizumab/Bevacizumab Versus Neoadjuvant Radiation Therapy

Conditions:   Hepatocellular Carcinoma;   Portal Vein Tumour Thrombosis Intervention:   Combination Product: Neoadjuvant Sponsors:   Ontario Clinical Oncology Group (OCOG);   Hoffmann-La Roche Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials